If elected, the Nominating Stockholders’ nominee
Post# of 148175
Quote:
If elected, the Nominating Stockholders’ nominees – Thomas Errico, MD, Bruce Patterson, MD, Paul Rosenbaum, Peter Staats, MD MBA, and Melissa Yeager – will take the steps necessary to earn FDA approval for Leronlimab and enhance long-term value for all stockholders.
What steps? You have had how many months now to tell us? Yet you still make this hollow statement.
What steps? What steps? What steps?